| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.791 | 0.003 | 0.791 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.618 0.004 CHEMBL2059159 0.286 0.009 CHEMBL2030560 | ||
| 0.777 | 0.003 | 0.777 | Raf kinase inhibitor | 0.615 0.004 CHEMBL2059159 0.264 0.008 CHEMBL2030560 | ||
| 0.748 | 0.001 | 0.748 | Raf kinase C inhibitor | 0.733 0.002 CHEMBL2059159 0.545 0.003 CHEMBL2030560 | ||
| 0.734 | 0.003 | 0.734 | Raf kinase B inhibitor | 0.56 0.004 CHEMBL2059159 0.216 0.008 CHEMBL2030560 | ||
| 0.596 | 0.006 | 0.596 | Calcium channel L-type activator | 0.484 0.034 CHEMBL2059159 0.561 0.011 CHEMBL2030560 | ||
| 0.436 | 0.005 | 0.436 | TIE antagonist | 0.208 0.014 CHEMBL2059159 0.185 0.017 CHEMBL2030560 | ||
| 0.44 | 0.018 | 0.44 | Antimitotic | 0.239 0.064 CHEMBL2059159 0.363 0.029 CHEMBL2030560 | ||
| 0.423 | 0.005 | 0.423 | TIE-2 antagonist | 0.197 0.015 CHEMBL2059159 0.176 0.018 CHEMBL2030560 | ||
| 0.388 | 0.029 | 0.408 | Calcium channel activator | 0.408 0.022 CHEMBL2030560 | CHEMBL2030560 | |
| 0.406 | 0.052 | 0.406 | Angiogenesis inhibitor | 0.214 0.154 CHEMBL2059159 0.3 0.093 CHEMBL2030560 | ||
| 0.374 | 0.02 | 0.374 | EphB2 antagonist | 0.301 0.035 CHEMBL2059159 0.154 0.125 CHEMBL2030560 | ||
| 0.344 | 0.004 | 0.344 | Potassium channel (Ca-activated) blocker | 0.139 0.005 CHEMBL2059159 0.332 0.004 CHEMBL2030560 | ||
| 0.328 | 0.016 | 0.328 | Tubulin antagonist | 0.177 0.045 CHEMBL2059159 0.235 0.028 CHEMBL2030560 | ||
| 0.342 | 0.048 | 0.342 | Hypoxia-inducible factor 1 alpha inhibitor | 0.229 0.119 CHEMBL2059159 0.226 0.123 CHEMBL2030560 | ||
| 0.276 | 0.005 | 0.276 | Hedgehog signaling inhibitor | 0.122 0.038 CHEMBL2059159 0.134 0.031 CHEMBL2030560 | ||
| 0.261 | 0.008 | 0.261 | Catalase inhibitor | 0.202 0.015 CHEMBL2059159 0.089 0.043 CHEMBL2030560 | ||
| 0.249 | 0.009 | 0.249 | Microtubule formation inhibitor | 0.186 0.023 CHEMBL2059159 0.128 0.053 CHEMBL2030560 | ||
| 0.277 | 0.042 | 0.277 | Platelet aggregation inhibitor | 0.173 0.104 CHEMBL2059159 | ||
| 0.241 | 0.007 | 0.241 | Gastric antisecretory | 0.158 0.023 CHEMBL2059159 0.161 0.022 CHEMBL2030560 | ||
| 0.229 | 0.012 | 0.534 | Check point kinase 2 inhibitor | 0.391 0.004 CHEMBL2059159 0.534 0.004 CHEMBL2030560 | CHEMBL2030560 | |
| 0.278 | 0.073 | 0.324 | Insulysin inhibitor | 0.324 0.045 CHEMBL2030560 | CHEMBL2030560 | |
| 0.347 | 0.148 | 0.349 | Caspase 9 stimulant | 0.283 0.213 CHEMBL2059159 0.349 0.146 CHEMBL2030560 | CHEMBL2030560 | |
| 0.289 | 0.097 | 0.291 | Vasodilator, coronary | 0.269 0.116 CHEMBL2059159 0.291 0.095 CHEMBL2030560 | CHEMBL2030560 | |
| 0.217 | 0.026 | 0.217 | ATPase inhibitor | 0.213 0.028 CHEMBL2059159 0.178 0.061 CHEMBL2030560 | ||
| 0.214 | 0.023 | 0.214 | Platelet activating factor antagonist | 0.105 0.074 CHEMBL2030560 | ||
| 0.29 | 0.1 | 0.418 | Transcription factor NF kappa B inhibitor | 0.418 0.06 CHEMBL2059159 0.244 0.132 CHEMBL2030560 | CHEMBL2059159 | |
| 0.2 | 0.016 | 0.2 | Platelet activating factor alpha antagonist | 0.094 0.064 CHEMBL2059159 | ||
| 0.189 | 0.014 | 0.497 | HIV-1 integrase (Overall Integration) inhibitor | 0.104 0.051 CHEMBL2059159 0.497 0.002 CHEMBL2030560 | CHEMBL2030560 | |
| 0.211 | 0.037 | 0.286 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.286 0.018 CHEMBL2030560 | CHEMBL2030560 | |
| 0.144 | 0.006 | 0.199 | Granulocyte macrophage colony stimulating factor agonist | 0.122 0.015 CHEMBL2059159 0.199 0.003 CHEMBL2030560 | CHEMBL2030560 | |
| 0.133 | 0.006 | 0.156 | Potassium channel (ATP-sensitive) blocker | 0.072 0.038 CHEMBL2059159 0.156 0.005 CHEMBL2030560 | CHEMBL2030560 | |
| 0.156 | 0.036 | 0.179 | Interleukin 1b antagonist | 0.179 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.173 | 0.054 | 0.173 | NOS3 expression enhancer | 0.162 0.062 CHEMBL2059159 0.169 0.057 CHEMBL2030560 | ||
| 0.186 | 0.072 | 0.362 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.137 0.107 CHEMBL2059159 0.362 0.017 CHEMBL2030560 | CHEMBL2030560 | |
| 0.131 | 0.019 | 0.131 | mTOR complex 1 inhibitor | 0.113 0.038 CHEMBL2059159 0.118 0.032 CHEMBL2030560 | ||
| 0.12 | 0.013 | 0.12 | DNA gyrase inhibitor | 0.104 0.017 CHEMBL2059159 | ||
| 0.166 | 0.059 | 0.407 | Protein kinase (CK1) gamma inhibitor | 0.407 0.007 CHEMBL2030560 | CHEMBL2030560 | |
| 0.122 | 0.019 | 0.125 | Prostaglandin-E synthase inhibitor | 0.125 0.018 CHEMBL2030560 | CHEMBL2030560 | |
| 0.237 | 0.135 | 0.378 | Cholesterol antagonist | 0.378 0.055 CHEMBL2059159 0.211 0.155 CHEMBL2030560 | CHEMBL2059159 | |
| 0.16 | 0.06 | 0.203 | Lck kinase inhibitor | 0.203 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.154 | 0.054 | 0.236 | MAP kinase kinase 4 inhibitor | 0.165 0.038 CHEMBL2059159 0.236 0.006 CHEMBL2030560 | CHEMBL2030560 | |
| 0.102 | 0.005 | 0.102 | Factor XIa inhibitor | 0.086 0.007 CHEMBL2059159 | ||
| 0.118 | 0.023 | 0.18 | Glutamate release inhibitor | 0.18 0.005 CHEMBL2030560 | CHEMBL2030560 | |
| 0.149 | 0.058 | 0.22 | Interleukin 1 antagonist | 0.22 0.026 CHEMBL2030560 | CHEMBL2030560 | |
| 0.148 | 0.058 | 0.152 | Pregnane X receptor agonist | 0.152 0.05 CHEMBL2030560 | CHEMBL2030560 | |
| 0.204 | 0.115 | 0.204 | Cardiotonic | 0.203 0.116 CHEMBL2059159 0.183 0.136 CHEMBL2030560 | ||
| 0.177 | 0.09 | 0.26 | Growth factor agonist | 0.26 0.028 CHEMBL2030560 | CHEMBL2030560 | |
| 0.141 | 0.054 | 0.141 | Antibacterial (Helicobacter pylori) | 0.138 0.058 CHEMBL2059159 0.133 0.063 CHEMBL2030560 | ||
| 0.133 | 0.05 | 0.164 | DNA repair enzyme inhibitor | 0.164 0.021 CHEMBL2030560 | CHEMBL2030560 | |
| 0.129 | 0.046 | 0.202 | Protein kinase C gamma inhibitor | 0.202 0.014 CHEMBL2030560 | CHEMBL2030560 | |
| 0.141 | 0.058 | 0.367 | Protein kinase (CK1) delta inhibitor | 0.367 0.008 CHEMBL2030560 | CHEMBL2030560 | |
| 0.107 | 0.028 | 0.112 | Histamine H2 receptor antagonist | 0.079 0.068 CHEMBL2059159 0.112 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.09 | 0.013 | 0.159 | Factor IXa inhibitor | 0.131 0.005 CHEMBL2059159 0.159 0.004 CHEMBL2030560 | CHEMBL2030560 | |
| 0.113 | 0.037 | 0.149 | Potassium channel activator | 0.149 0.021 CHEMBL2059159 0.093 0.057 CHEMBL2030560 | CHEMBL2059159 | |
| 0.136 | 0.06 | 0.136 | Vascular endothelial growth factor antagonist | 0.093 0.088 CHEMBL2030560 | ||
| 0.185 | 0.111 | 0.419 | Aryl hydrocarbon receptor agonist | 0.419 0.034 CHEMBL2030560 | CHEMBL2030560 | |
| 0.092 | 0.018 | 0.092 | CDK4/cyclin D1 inhibitor | 0.084 0.022 CHEMBL2030560 | ||
| 0.159 | 0.089 | 0.226 | LIM domain kinase 1 inhibitor | 0.226 0.051 CHEMBL2030560 | CHEMBL2030560 | |
| 0.123 | 0.053 | 0.138 | Photosensitizer | 0.138 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.173 | 0.103 | 0.173 | Insulin sensitizer | 0.157 0.124 CHEMBL2030560 | ||
| 0.125 | 0.058 | 0.125 | Vascular endothelial growth factor 2 antagonist | |||
| 0.109 | 0.046 | 0.175 | CDK/cyclin complex inhibitor | 0.175 0.023 CHEMBL2030560 | CHEMBL2030560 | |
| 0.067 | 0.005 | 0.067 | Factor XI inhibitor | 0.055 0.008 CHEMBL2059159 | ||
| 0.077 | 0.023 | 0.08 | CDK4/cyclin D inhibitor | 0.08 0.022 CHEMBL2030560 | CHEMBL2030560 | |
| 0.096 | 0.044 | 0.164 | Platelet growth factor antagonist | 0.164 0.015 CHEMBL2030560 | CHEMBL2030560 | |
| 0.181 | 0.131 | 0.303 | RNA-directed DNA polymerase inhibitor | 0.303 0.031 CHEMBL2030560 | CHEMBL2030560 | |
| 0.053 | 0.004 | 0.053 | HCV NS5A inhibitor | 0.045 0.004 CHEMBL2059159 | ||
| 0.114 | 0.066 | 0.141 | Protein kinase (CK2) alpha inhibitor | 0.089 0.088 CHEMBL2059159 0.141 0.047 CHEMBL2030560 | CHEMBL2030560 | |
| 0.283 | 0.236 | 0.406 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.406 0.096 CHEMBL2030560 | CHEMBL2030560 | |
| 0.073 | 0.027 | 0.089 | Transcription factor AP-1 inhibitor | 0.089 0.017 CHEMBL2059159 | CHEMBL2059159 | |
| 0.069 | 0.024 | 0.069 | Alpha tubulin antagonist | 0.06 0.03 CHEMBL2059159 | ||
| 0.147 | 0.104 | 0.17 | Tumour necrosis factor antagonist | 0.17 0.077 CHEMBL2030560 | CHEMBL2030560 | |
| 0.07 | 0.028 | 0.08 | Cyclin D1 inhibitor | 0.08 0.018 CHEMBL2030560 | CHEMBL2030560 | |
| 0.098 | 0.057 | 0.098 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.1 | 0.063 | 0.127 | Cyclin-dependent kinase 9 inhibitor | 0.127 0.042 CHEMBL2030560 | CHEMBL2030560 | |
| 0.124 | 0.088 | 0.368 | Protein kinase (CK1) inhibitor | 0.368 0.01 CHEMBL2030560 | CHEMBL2030560 | |
| 0.109 | 0.075 | 0.344 | Protein kinase (CK1) gamma 2 inhibitor | 0.344 0.006 CHEMBL2030560 | CHEMBL2030560 | |
| 0.036 | 0.005 | 0.041 | Acid ceramidase inhibitor | 0.041 0.004 CHEMBL2030560 | CHEMBL2030560 | |
| 0.148 | 0.117 | 0.287 | Pyruvate kinase inhibitor | 0.287 0.051 CHEMBL2030560 | CHEMBL2030560 | |
| 0.135 | 0.107 | 0.249 | Protein kinase (CK1) gamma 3 inhibitor | 0.249 0.027 CHEMBL2030560 | CHEMBL2030560 | |
| 0.108 | 0.08 | 0.189 | Interleukin 8 antagonist | 0.189 0.016 CHEMBL2030560 | CHEMBL2030560 | |
| 0.03 | 0.003 | 0.048 | Granulocyte colony stimulating factor receptor agonist | 0.027 0.004 CHEMBL2059159 0.048 0.002 CHEMBL2030560 | CHEMBL2030560 | |
| 0.12 | 0.095 | 0.209 | CDC-like kinase 1 inhibitor | 0.209 0.031 CHEMBL2030560 | CHEMBL2030560 | |
| 0.157 | 0.133 | 0.455 | Aldehyde oxidase inhibitor | 0.455 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.062 | 0.039 | 0.062 | Beta tubulin antagonist | |||
| 0.227 | 0.204 | 0.227 | Transcription factor inhibitor | |||
| 0.048 | 0.026 | 0.074 | Potassium channel small-conductance Ca-activated blocker | 0.074 0.012 CHEMBL2030560 | CHEMBL2030560 | |
| 0.115 | 0.093 | 0.246 | Interleukin 4 antagonist | 0.126 0.077 CHEMBL2059159 0.246 0.014 CHEMBL2030560 | CHEMBL2030560 | |
| 0.033 | 0.015 | 0.035 | Elastase 2B inhibitor | 0.035 0.013 CHEMBL2030560 | CHEMBL2030560 | |
| 0.033 | 0.015 | 0.035 | Elastase 3A inhibitor | 0.035 0.013 CHEMBL2030560 | CHEMBL2030560 | |
| 0.033 | 0.015 | 0.035 | Elastase 3B inhibitor | 0.035 0.013 CHEMBL2030560 | CHEMBL2030560 | |
| 0.06 | 0.044 | 0.099 | Cyclin B1 inhibitor | 0.099 0.011 CHEMBL2030560 | CHEMBL2030560 | |
| 0.099 | 0.083 | 0.104 | CDC-like kinase 3 inhibitor | 0.104 0.07 CHEMBL2030560 | CHEMBL2030560 | |
| 0.106 | 0.09 | 0.212 | MAP kinase 12 inhibitor | 0.212 0.019 CHEMBL2030560 | CHEMBL2030560 | |
| 0.05 | 0.035 | 0.069 | Potassium channel (Inward rectifier) activator | 0.069 0.012 CHEMBL2059159 0.061 0.019 CHEMBL2030560 | CHEMBL2059159 | |
| 0.143 | 0.128 | 0.143 | P-glycoprotein inhibitor | |||
| 0.054 | 0.04 | 0.09 | Cyclin B2 inhibitor | 0.09 0.011 CHEMBL2030560 | CHEMBL2030560 | |
| 0.048 | 0.034 | 0.065 | Potassium channel (ATP-sensitive) activator | 0.065 0.012 CHEMBL2059159 0.058 0.018 CHEMBL2030560 | CHEMBL2059159 | |
| 0.112 | 0.098 | 0.189 | Cytokine production inhibitor | 0.189 0.04 CHEMBL2059159 | CHEMBL2059159 | |
| 0.083 | 0.071 | 0.083 | ATPase (Vacuolar H+) inhibitor | |||
| 0.141 | 0.13 | 0.282 | I kappa B kinase epsilon inhibitor | 0.282 0.022 CHEMBL2030560 | CHEMBL2030560 | |
| 0.079 | 0.067 | 0.088 | Stem cell growth factor agonist | 0.088 0.056 CHEMBL2030560 | CHEMBL2030560 | |
| 0.075 | 0.064 | 0.104 | MAP kinase kinase 7 inhibitor | 0.073 0.069 CHEMBL2059159 0.104 0.01 CHEMBL2030560 | CHEMBL2030560 | |
| 0.032 | 0.021 | 0.054 | Cholesterol ester transfer protein antagonist | 0.054 0.005 CHEMBL2059159 | CHEMBL2059159 | |
| 0.092 | 0.083 | 0.222 | Folate antagonist | 0.093 0.079 CHEMBL2059159 0.222 0.007 CHEMBL2030560 | CHEMBL2030560 | |
| 0.062 | 0.053 | 0.062 | Alpha adrenoreceptor agonist | 0.06 0.055 CHEMBL2030560 | ||
| 0.056 | 0.048 | 0.056 | Alpha 2 adrenoreceptor agonist | 0.055 0.05 CHEMBL2030560 | ||
| 0.048 | 0.041 | 0.06 | H+/K+-transporting ATPase inhibitor | 0.06 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.051 | 0.044 | 0.052 | Heparanase inhibitor | 0.052 0.04 CHEMBL2030560 | CHEMBL2030560 | |
| 0.016 | 0.009 | 0.02 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.02 0.004 CHEMBL2030560 | CHEMBL2030560 | |
| 0.059 | 0.053 | 0.079 | Fibroblast growth factor 2 antagonist | 0.079 0.034 CHEMBL2030560 | CHEMBL2030560 | |
| 0.029 | 0.024 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.026 CHEMBL2059159 | ||
| 0.075 | 0.072 | 0.076 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.072 CHEMBL2030560 | CHEMBL2030560 | |
| 0.054 | 0.053 | 0.17 | CDK1/cyclin B inhibitor | 0.17 0.011 CHEMBL2030560 | CHEMBL2030560 | |
| 0.086 | 0.085 | 0.157 | Insulin receptor antagonist | 0.157 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.049 | 0.049 | 0.085 | Cyclin B inhibitor | 0.085 0.013 CHEMBL2030560 | CHEMBL2030560 | |
| 0.213 | 0.214 | 0.355 | Antibacterial | 0.355 0.099 CHEMBL2059159 0.269 0.16 CHEMBL2030560 | CHEMBL2059159 | |
| 0.047 | 0.049 | 0.078 | Protein kinase C eta inhibitor | 0.078 0.024 CHEMBL2030560 | CHEMBL2030560 | |
| 0.079 | 0.081 | 0.123 | CDK2/cyclin A inhibitor | 0.123 0.04 CHEMBL2030560 | CHEMBL2030560 | |
| 0.014 | 0.019 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.02 0.007 CHEMBL2030560 | CHEMBL2030560 | |
| 0.079 | 0.084 | 0.106 | Protein kinase (CK2) inhibitor | 0.106 0.059 CHEMBL2030560 | CHEMBL2030560 | |
| 0.24 | 0.247 | 0.259 | MAP kinase 1 inhibitor | 0.259 0.223 CHEMBL2030560 | CHEMBL2030560 | |
| 0.139 | 0.147 | 0.444 | Dyrk kinase inhibitor | 0.444 0.02 CHEMBL2030560 | CHEMBL2030560 | |
| 0.041 | 0.049 | 0.058 | Potassium channel (Inward rectifier) blocker | 0.058 0.026 CHEMBL2030560 | CHEMBL2030560 | |
| 0.176 | 0.185 | 0.226 | Gastrin inhibitor | 0.226 0.111 CHEMBL2030560 | CHEMBL2030560 | |
| 0.03 | 0.039 | 0.037 | Protein kinase C beta I inhibitor | 0.037 0.014 CHEMBL2030560 | CHEMBL2030560 | |
| 0.044 | 0.054 | 0.134 | Tyrosine-protein kinase EMT inhibitor | 0.134 0.011 CHEMBL2030560 | CHEMBL2030560 | |
| 0.032 | 0.043 | 0.089 | CDK5/p25 inhibitor | 0.089 0.008 CHEMBL2030560 | CHEMBL2030560 | |
| 0.007 | 0.022 | 0.011 | Imidazoline I2 receptor antagonist | 0.011 0.008 CHEMBL2030560 | CHEMBL2030560 | |
| 0.075 | 0.091 | 0.113 | Hematopoietic | 0.113 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.027 | 0.044 | 0.074 | Diamine oxidase inhibitor | 0.074 0.006 CHEMBL2030560 | CHEMBL2030560 | |
| 0.07 | 0.089 | 0.081 | MAP kinase 7 inhibitor | 0.081 0.042 CHEMBL2030560 | CHEMBL2030560 | |
| 0.073 | 0.091 | 0.094 | mTOR complex 2 inhibitor | 0.094 0.04 CHEMBL2030560 | CHEMBL2030560 | |
| 0.086 | 0.105 | 0.2 | MAP kinase 13 inhibitor | 0.2 0.021 CHEMBL2030560 | CHEMBL2030560 | |
| 0.027 | 0.047 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.017 CHEMBL2030560 | CHEMBL2030560 | |
| 0.059 | 0.079 | 0.185 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.094 0.039 CHEMBL2059159 0.185 0.015 CHEMBL2030560 | CHEMBL2030560 | |
| 0.086 | 0.11 | 0.133 | DOPA decarboxylase inhibitor | 0.133 0.032 CHEMBL2030560 | CHEMBL2030560 | |
| 0.071 | 0.096 | 0.239 | Cyclin-dependent kinase 1 inhibitor | 0.239 0.019 CHEMBL2030560 | CHEMBL2030560 | |
| 0.149 | 0.175 | 0.236 | DNA damaging | 0.236 0.089 CHEMBL2030560 | CHEMBL2030560 | |
| 0.062 | 0.089 | 0.099 | Ornithine decarboxylase inhibitor | 0.099 0.046 CHEMBL2059159 | CHEMBL2059159 | |
| 0.041 | 0.07 | 0.076 | Adenosine A2a receptor antagonist | 0.076 0.034 CHEMBL2030560 | CHEMBL2030560 | |
| 0.229 | 0.259 | 0.325 | 5 Hydroxytryptamine release inhibitor | 0.325 0.139 CHEMBL2030560 | CHEMBL2030560 | |
| 0.036 | 0.069 | 0.093 | CDK2/cyclin E inhibitor | 0.093 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.026 | 0.058 | 0.042 | Urokinase inhibitor | 0.042 0.037 CHEMBL2030560 | CHEMBL2030560 | |
| 0.024 | 0.057 | 0.034 | Protein kinase C beta II inhibitor | 0.034 0.02 CHEMBL2030560 | CHEMBL2030560 | |
| 0.029 | 0.063 | 0.051 | Protein kinase (CK1) epsilon inhibitor | 0.051 0.012 CHEMBL2030560 | CHEMBL2030560 | |
| 0.112 | 0.146 | 0.162 | GABA C receptor rho-2 antagonist | 0.162 0.059 CHEMBL2030560 | CHEMBL2030560 | |
| 0.048 | 0.082 | 0.149 | Cyclin B3 inhibitor | 0.149 0.014 CHEMBL2030560 | CHEMBL2030560 | |
| 0.044 | 0.079 | 0.085 | Cyclin-dependent kinase 4 inhibitor | 0.085 0.032 CHEMBL2030560 | CHEMBL2030560 | |
| 0.035 | 0.069 | 0.145 | Adenosine A1 receptor antagonist | 0.145 0.016 CHEMBL2030560 | CHEMBL2030560 | |
| 0.06 | 0.096 | 0.083 | Carbonic anhydrase VI inhibitor | 0.083 0.053 CHEMBL2030560 | CHEMBL2030560 | |
| 0.125 | 0.162 | 0.427 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.427 0.021 CHEMBL2030560 | CHEMBL2030560 | |
| 0.047 | 0.084 | 0.099 | 5 Hydroxytryptamine 5A antagonist | 0.099 0.016 CHEMBL2030560 | CHEMBL2030560 | |
| 0.055 | 0.097 | 0.077 | Adenosine A3 receptor antagonist | 0.077 0.047 CHEMBL2030560 | CHEMBL2030560 | |
| 0.042 | 0.085 | 0.089 | 5 Hydroxytryptamine 5 antagonist | 0.089 0.017 CHEMBL2030560 | CHEMBL2030560 | |
| 0.185 | 0.229 | 0.227 | 15-Lipoxygenase inhibitor | 0.227 0.185 CHEMBL2030560 | CHEMBL2030560 | |
| 0.048 | 0.095 | 0.106 | Interferon inducer | 0.064 0.045 CHEMBL2059159 0.106 0.01 CHEMBL2030560 | CHEMBL2030560 | |
| 0.039 | 0.085 | 0.08 | Adenosine A2 receptor antagonist | 0.08 0.035 CHEMBL2030560 | CHEMBL2030560 | |
| 0.007 | 0.058 | 0.022 | Sodium/hydrogen exchanger inhibitor | 0.022 0.008 CHEMBL2030560 | CHEMBL2030560 | |
| 0.067 | 0.119 | 0.119 | DNA directed RNA polymerase inhibitor | 0.119 0.038 CHEMBL2030560 | CHEMBL2030560 | |
| 0.028 | 0.081 | 0.053 | Adenosine A2b receptor antagonist | 0.053 0.031 CHEMBL2030560 | CHEMBL2030560 | |
| 0.049 | 0.103 | 0.063 | Transforming growth factor antagonist | 0.063 0.061 CHEMBL2030560 | CHEMBL2030560 | |
| 0.024 | 0.079 | 0.049 | MAP3K5 inhibitor | 0.049 0.013 CHEMBL2030560 | CHEMBL2030560 | |
| 0.09 | 0.145 | 0.156 | Src kinase inhibitor | 0.156 0.079 CHEMBL2030560 | CHEMBL2030560 | |
| 0.044 | 0.102 | 0.087 | Protein kinase C beta inhibitor | 0.087 0.021 CHEMBL2030560 | CHEMBL2030560 | |
| 0.131 | 0.191 | 0.178 | Cyclic AMP phosphodiesterase inhibitor | 0.169 0.124 CHEMBL2059159 0.178 0.114 CHEMBL2030560 | CHEMBL2030560 | |
| 0.07 | 0.13 | 0.202 | Nav1.1 sodium channel blocker | 0.202 0.018 CHEMBL2030560 | CHEMBL2030560 | |
| 0.08 | 0.141 | 0.232 | Ribosomal protein S6 kinase inhibitor | 0.232 0.026 CHEMBL2030560 | CHEMBL2030560 | |
| 0.053 | 0.114 | 0.115 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.115 0.007 CHEMBL2030560 | CHEMBL2030560 | |
| 0.055 | 0.117 | 0.09 | Insulin growth factor antagonist | 0.09 0.054 CHEMBL2030560 | CHEMBL2030560 | |
| 0.11 | 0.174 | 0.147 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.147 0.078 CHEMBL2030560 | CHEMBL2030560 | |
| 0.079 | 0.145 | 0.134 | CDK3/cyclin E inhibitor | 0.134 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.072 | 0.137 | 0.172 | Amylase inhibitor | 0.172 0.054 CHEMBL2030560 | CHEMBL2030560 | |
| 0.081 | 0.147 | 0.107 | Toll-Like receptor 2 antagonist | 0.107 0.093 CHEMBL2030560 | CHEMBL2030560 | |
| 0.072 | 0.139 | 0.165 | Nav1.4 sodium channel blocker | 0.165 0.028 CHEMBL2030560 | CHEMBL2030560 | |
| 0.138 | 0.206 | 0.159 | MAP kinase kinase 5 inhibitor | 0.159 0.119 CHEMBL2030560 | CHEMBL2030560 | |
| 0.052 | 0.121 | 0.124 | Fibroblast growth factor 1 antagonist | 0.124 0.041 CHEMBL2030560 | CHEMBL2030560 | |
| 0.005 | 0.075 | 0.013 | Purine nucleoside phosphorylase inhibitor | 0.013 0.006 CHEMBL2030560 | CHEMBL2030560 | |
| 0.024 | 0.093 | 0.064 | Nicotinic acid receptor 1 agonist | 0.064 0.015 CHEMBL2030560 | CHEMBL2030560 | |
| 0.086 | 0.157 | 0.346 | Protein kinase (CK1) gamma 1 inhibitor | 0.346 0.013 CHEMBL2030560 | CHEMBL2030560 | |
| 0.048 | 0.119 | 0.111 | Platelet activating factor beta antagonist | 0.111 0.055 CHEMBL2030560 | CHEMBL2030560 | |
| 0.069 | 0.14 | 0.172 | Cyclin-dependent kinase inhibitor | 0.172 0.046 CHEMBL2030560 | CHEMBL2030560 | |
| 0.144 | 0.216 | 0.225 | DNA synthesis inhibitor | 0.209 0.11 CHEMBL2059159 0.225 0.088 CHEMBL2030560 | CHEMBL2030560 | |
| 0.096 | 0.168 | 0.148 | Arachidonic acid antagonist | 0.148 0.091 CHEMBL2030560 | CHEMBL2030560 | |
| 0.039 | 0.111 | 0.124 | CDK1/cyclin B1 inhibitor | 0.124 0.021 CHEMBL2030560 | CHEMBL2030560 | |
| 0.029 | 0.103 | 0.078 | p38 MAP kinase inhibitor | 0.078 0.041 CHEMBL2030560 | CHEMBL2030560 | |
| 0.065 | 0.141 | 0.184 | Adenylate cyclase inhibitor | 0.184 0.029 CHEMBL2030560 | CHEMBL2030560 | |
| 0.057 | 0.133 | 0.081 | Antihistaminic | 0.081 0.076 CHEMBL2030560 | CHEMBL2030560 | |
| 0.025 | 0.101 | 0.075 | Dihydrofolate reductase inhibitor | 0.075 0.005 CHEMBL2030560 | CHEMBL2030560 | |
| 0.05 | 0.127 | 0.126 | Interferon agonist | 0.071 0.068 CHEMBL2059159 0.126 0.015 CHEMBL2030560 | CHEMBL2030560 | |
| 0.082 | 0.164 | 0.402 | Peroxidase inhibitor | 0.402 0.02 CHEMBL2030560 | CHEMBL2030560 | |
| 0.059 | 0.141 | 0.134 | Glycogen synthase kinase-3 beta inhibitor | 0.134 0.052 CHEMBL2030560 | CHEMBL2030560 | |
| 0.059 | 0.143 | 0.136 | Glycogen synthase kinase-3 inhibitor | 0.136 0.052 CHEMBL2030560 | CHEMBL2030560 | |
| 0.012 | 0.098 | 0.025 | Toll-Like receptor 8 agonist | 0.025 0.007 CHEMBL2030560 | CHEMBL2030560 | |
| 0.033 | 0.119 | 0.105 | MAP kinase 11 inhibitor | 0.105 0.033 CHEMBL2030560 | CHEMBL2030560 | |
| 0.038 | 0.125 | 0.065 | Benzodiazepine agonist | 0.065 0.059 CHEMBL2030560 | CHEMBL2030560 | |
| 0.07 | 0.158 | 0.138 | Adenylate kinase inhibitor | 0.138 0.031 CHEMBL2030560 | CHEMBL2030560 | |
| 0.123 | 0.212 | 0.182 | Histone acetyltransferase inhibitor | 0.182 0.097 CHEMBL2030560 | CHEMBL2030560 | |
| 0.019 | 0.107 | 0.054 | Antimetabolite | 0.054 0.029 CHEMBL2030560 | CHEMBL2030560 | |
| 0.101 | 0.192 | 0.186 | DNA methylase inhibitor | 0.186 0.088 CHEMBL2030560 | CHEMBL2030560 | |
| 0.008 | 0.101 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 CHEMBL2030560 | CHEMBL2030560 | |
| 0.033 | 0.127 | 0.065 | MAP kinase 14 inhibitor | 0.065 0.06 CHEMBL2030560 | CHEMBL2030560 | |
| 0.146 | 0.24 | 0.185 | 5 Hydroxytryptamine 3E antagonist | 0.185 0.092 CHEMBL2030560 | CHEMBL2030560 | |
| 0.031 | 0.126 | 0.097 | CDC7 inhibitor | 0.097 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.013 | 0.108 | 0.037 | CDK4/cyclin D3 inhibitor | 0.037 0.011 CHEMBL2030560 | CHEMBL2030560 | |
| 0.037 | 0.133 | 0.093 | Protein kinase C alpha inhibitor | 0.093 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.057 | 0.155 | 0.118 | NADH dehydrogenase inhibitor | 0.118 0.03 CHEMBL2030560 | CHEMBL2030560 | |
| 0.02 | 0.118 | 0.059 | Histamine H2 receptor agonist | 0.059 0.015 CHEMBL2030560 | CHEMBL2030560 | |
| 0.09 | 0.189 | 0.272 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.272 0.036 CHEMBL2030560 | CHEMBL2030560 | |
| 0.087 | 0.188 | 0.242 | Clk dual-specificity kinase inhibitor | 0.242 0.058 CHEMBL2030560 | CHEMBL2030560 | |
| 0.066 | 0.167 | 0.144 | Cyclin-dependent kinase 7 inhibitor | 0.144 0.064 CHEMBL2030560 | CHEMBL2030560 | |
| 0.056 | 0.159 | 0.147 | Cyclin-dependent kinase 2 inhibitor | 0.147 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.141 | 0.244 | 0.264 | Nitric-oxide synthase stimulant | 0.264 0.024 CHEMBL2030560 | CHEMBL2030560 | |
| 0.019 | 0.125 | 0.086 | Thymidylate synthase inhibitor | 0.086 0.005 CHEMBL2030560 | CHEMBL2030560 | |
| 0.087 | 0.194 | 0.189 | Heat shock protein 90 antagonist | 0.189 0.043 CHEMBL2030560 | CHEMBL2030560 | |
| 0.073 | 0.182 | 0.113 | Activin receptor-like kinase 2 inhibitor | 0.113 0.106 CHEMBL2030560 | CHEMBL2030560 | |
| 0.05 | 0.159 | 0.116 | Protein kinase C delta inhibitor | 0.116 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.103 | 0.214 | 0.152 | 3C-like protease (Human coronavirus) inhibitor | 0.152 0.098 CHEMBL2030560 | CHEMBL2030560 | |
| 0.1 | 0.211 | 0.321 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.321 0.037 CHEMBL2030560 | CHEMBL2030560 | |
| 0.113 | 0.226 | 0.217 | Streptokinase A inhibitor | 0.217 0.122 CHEMBL2030560 | CHEMBL2030560 | |
| 0.035 | 0.149 | 0.055 | Heat shock protein 90 beta antagonist | 0.055 0.048 CHEMBL2030560 | CHEMBL2030560 | |
| 0.028 | 0.142 | 0.053 | Androgen agonist | 0.053 0.052 CHEMBL2059159 | CHEMBL2059159 | |
| 0.157 | 0.275 | 0.424 | GABA C receptor rho-3 antagonist | 0.424 0.052 CHEMBL2030560 | CHEMBL2030560 | |
| 0.026 | 0.144 | 0.046 | Aldosterone antagonist | 0.046 0.035 CHEMBL2030560 | CHEMBL2030560 | |
| 0.059 | 0.179 | 0.129 | MAP kinase kinase 1 inhibitor | 0.129 0.028 CHEMBL2059159 0.118 0.037 CHEMBL2030560 | CHEMBL2059159 | |
| 0.025 | 0.151 | 0.103 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.103 0.014 CHEMBL2030560 | CHEMBL2030560 | |
| 0.068 | 0.195 | 0.161 | Protein kinase C nu inhibitor | 0.161 0.064 CHEMBL2030560 | CHEMBL2030560 | |
| 0.058 | 0.186 | 0.089 | D-Ala-D-Ala ligase inhibitor | 0.089 0.047 CHEMBL2030560 | CHEMBL2030560 | |
| 0.155 | 0.285 | 0.284 | Interleukin 2 agonist | 0.284 0.086 CHEMBL2030560 | CHEMBL2030560 | |
| 0.119 | 0.25 | 0.238 | Superoxide dismutase inhibitor | 0.238 0.083 CHEMBL2030560 | CHEMBL2030560 | |
| 0.013 | 0.143 | 0.06 | Dihydropteroate synthase inhibitor | 0.06 0.011 CHEMBL2030560 | CHEMBL2030560 | |
| 0.054 | 0.188 | 0.11 | Thioredoxin inhibitor | 0.11 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.042 | 0.177 | 0.067 | Glycine receptor agonist | 0.067 0.06 CHEMBL2030560 | CHEMBL2030560 | |
| 0.009 | 0.146 | 0.036 | Phosphoglycerate kinase inhibitor | 0.036 0.024 CHEMBL2030560 | CHEMBL2030560 | |
| 0.037 | 0.174 | 0.128 | Protein kinase A inhibitor | 0.128 0.031 CHEMBL2030560 | CHEMBL2030560 | |
| 0.083 | 0.22 | 0.191 | Heat shock protein 90 alpha antagonist | 0.191 0.055 CHEMBL2030560 | CHEMBL2030560 | |
| 0.038 | 0.178 | 0.15 | Myeloperoxidase inhibitor | 0.15 0.011 CHEMBL2030560 | CHEMBL2030560 | |
| 0.135 | 0.276 | 0.214 | Antithrombotic | 0.214 0.16 CHEMBL2059159 | CHEMBL2059159 | |
| 0.079 | 0.22 | 0.138 | Mannose-6-phosphate isomerase inhibitor | 0.138 0.076 CHEMBL2030560 | CHEMBL2030560 | |
| 0.163 | 0.304 | 0.231 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.231 0.094 CHEMBL2030560 | CHEMBL2030560 | |
| 0.027 | 0.169 | 0.071 | Check point kinase 1 inhibitor | 0.071 0.045 CHEMBL2030560 | CHEMBL2030560 | |
| 0.053 | 0.196 | 0.108 | Xanthine oxidase inhibitor | 0.108 0.054 CHEMBL2030560 | CHEMBL2030560 | |
| 0.055 | 0.199 | 0.172 | MAP kinase kinase inhibitor | 0.138 0.059 CHEMBL2059159 0.172 0.04 CHEMBL2030560 | CHEMBL2030560 | |
| 0.057 | 0.201 | 0.119 | Tyrosine-protein kinase receptor antagonist | 0.119 0.088 CHEMBL2030560 | CHEMBL2030560 | |
| 0.092 | 0.238 | 0.163 | MAP kinase 3 inhibitor | 0.163 0.051 CHEMBL2030560 | CHEMBL2030560 | |
| 0.052 | 0.198 | 0.11 | GABA C receptor rho-1 antagonist | 0.11 0.049 CHEMBL2030560 | CHEMBL2030560 | |
| 0.051 | 0.2 | 0.085 | Bromodomain-containing protein 2 inhibitor | 0.085 0.066 CHEMBL2059159 | CHEMBL2059159 | |
| 0.024 | 0.175 | 0.065 | Histamine H4 receptor antagonist | 0.065 0.015 CHEMBL2030560 | CHEMBL2030560 | |
| 0.046 | 0.197 | 0.132 | Protein-tyrosine kinase Lyn inhibitor | 0.132 0.076 CHEMBL2030560 | CHEMBL2030560 | |
| 0.025 | 0.176 | 0.064 | Carbonic anhydrase stimulant | 0.064 0.037 CHEMBL2030560 | CHEMBL2030560 | |
| 0.105 | 0.257 | 0.142 | Death-associated protein kinase 2 inhibitor | 0.142 0.125 CHEMBL2030560 | CHEMBL2030560 | |
| 0.046 | 0.199 | 0.145 | Ferrochelatase inhibitor | 0.145 0.04 CHEMBL2030560 | CHEMBL2030560 | |
| 0.057 | 0.215 | 0.111 | Toll-Like receptor 9 antagonist | 0.111 0.097 CHEMBL2030560 | CHEMBL2030560 | |
| 0.08 | 0.238 | 0.199 | Interleukin antagonist | 0.199 0.084 CHEMBL2030560 | CHEMBL2030560 | |
| 0.035 | 0.195 | 0.082 | Secretase beta inhibitor | 0.082 0.034 CHEMBL2030560 | CHEMBL2030560 | |
| 0.035 | 0.199 | 0.113 | Histamine N-methyltransferase inhibitor | 0.113 0.035 CHEMBL2030560 | CHEMBL2030560 | |
| 0.056 | 0.221 | 0.13 | Toll-Like receptor 3 antagonist | 0.13 0.023 CHEMBL2030560 | CHEMBL2030560 | |
| 0.02 | 0.185 | 0.076 | Biliverdin reductase inhibitor | 0.076 0.028 CHEMBL2030560 | CHEMBL2030560 | |
| 0.029 | 0.194 | 0.08 | Phospholipase D inhibitor | 0.08 0.035 CHEMBL2030560 | CHEMBL2030560 | |
| 0.018 | 0.184 | 0.045 | Histamine H1 receptor agonist | 0.045 0.028 CHEMBL2030560 | CHEMBL2030560 | |
| 0.102 | 0.268 | 0.179 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.179 0.095 CHEMBL2030560 | CHEMBL2030560 | |
| 0.136 | 0.303 | 0.223 | Tyrosine 3 hydroxylase inhibitor | 0.223 0.099 CHEMBL2030560 | CHEMBL2030560 | |
| 0.048 | 0.217 | 0.122 | Protein kinase C zeta inhibitor | 0.122 0.031 CHEMBL2030560 | CHEMBL2030560 | |
| 0.004 | 0.173 | 0.032 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.032 0.016 CHEMBL2030560 | CHEMBL2030560 | |
| 0.02 | 0.188 | 0.073 | Cyclin A2 inhibitor | 0.073 0.036 CHEMBL2030560 | CHEMBL2030560 | |
| 0.108 | 0.28 | 0.135 | Ca2+-transporting ATPase inhibitor | 0.135 0.096 CHEMBL2030560 | CHEMBL2030560 | |
| 0.043 | 0.218 | 0.166 | GABA C receptor agonist | 0.166 0.028 CHEMBL2030560 | CHEMBL2030560 | |
| 0.014 | 0.189 | 0.062 | Xanthine dehydrogenase inhibitor | 0.062 0.037 CHEMBL2030560 | CHEMBL2030560 | |
| 0.035 | 0.21 | 0.143 | Cyclin-dependent kinase 5 inhibitor | 0.143 0.044 CHEMBL2030560 | CHEMBL2030560 | |
| 0.167 | 0.342 | 0.313 | MAP kinase kinase 6 inhibitor | 0.313 0.123 CHEMBL2030560 | CHEMBL2030560 | |
| 0.126 | 0.304 | 0.251 | DNA directed DNA polymerase inhibitor | 0.251 0.191 CHEMBL2030560 | CHEMBL2030560 | |
| 0.018 | 0.201 | 0.056 | AICAR transformylase inhibitor | 0.056 0.017 CHEMBL2030560 | CHEMBL2030560 | |
| 0.047 | 0.23 | 0.238 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.238 0.039 CHEMBL2030560 | CHEMBL2030560 | |
| 0.022 | 0.207 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.055 0.022 CHEMBL2030560 | CHEMBL2030560 | |
| 0.049 | 0.234 | 0.116 | Electrolyte absorption antagonist | 0.116 0.04 CHEMBL2030560 | CHEMBL2030560 | |
| 0.056 | 0.242 | 0.159 | CDC-like kinase 4 inhibitor | 0.159 0.094 CHEMBL2030560 | CHEMBL2030560 | |
| 0.043 | 0.23 | 0.086 | Phosphodiesterase I inhibitor | 0.086 0.065 CHEMBL2030560 | CHEMBL2030560 | |
| 0.017 | 0.208 | 0.064 | Cyclin A inhibitor | 0.064 0.041 CHEMBL2030560 | CHEMBL2030560 | |
| 0.036 | 0.227 | 0.052 | Immunoglobulin Fc receptor antagonist | 0.052 0.048 CHEMBL2030560 | CHEMBL2030560 | |
| 0.064 | 0.256 | 0.169 | Diuretic | 0.169 0.062 CHEMBL2030560 | CHEMBL2030560 | |
| 0.042 | 0.235 | 0.117 | 5 Hydroxytryptamine 3A agonist | 0.117 0.059 CHEMBL2030560 | CHEMBL2030560 | |
| 0.121 | 0.315 | 0.305 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.305 0.06 CHEMBL2030560 | CHEMBL2030560 | |
| 0.014 | 0.216 | 0.042 | Adenosine deaminase inhibitor | 0.042 0.038 CHEMBL2030560 | CHEMBL2030560 | |
| 0.047 | 0.249 | 0.187 | CDC-like kinase 2 inhibitor | 0.187 0.074 CHEMBL2030560 | CHEMBL2030560 | |
| 0.019 | 0.224 | 0.076 | 5 Hydroxytryptamine 3A antagonist | 0.076 0.035 CHEMBL2030560 | CHEMBL2030560 | |
| 0.129 | 0.335 | 0.313 | Histamine release inhibitor | 0.242 0.161 CHEMBL2059159 0.313 0.117 CHEMBL2030560 | CHEMBL2030560 | |
| 0.039 | 0.245 | 0.091 | Uric acid excretion stimulant | 0.091 0.063 CHEMBL2030560 | CHEMBL2030560 | |
| 0.03 | 0.238 | 0.094 | Adrenaline agonist | 0.094 0.042 CHEMBL2059159 | CHEMBL2059159 | |
| 0.02 | 0.231 | 0.172 | Phenylalanine 4-hydroxylase inhibitor | 0.172 0.009 CHEMBL2030560 | CHEMBL2030560 | |
| 0.137 | 0.348 | 0.204 | 5 Hydroxytryptamine uptake stimulant | 0.204 0.143 CHEMBL2030560 | CHEMBL2030560 | |
| 0.106 | 0.318 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.114 CHEMBL2030560 | CHEMBL2030560 | |
| 0.028 | 0.242 | 0.097 | MAP kinase kinase kinase inhibitor | 0.097 0.069 CHEMBL2030560 | CHEMBL2030560 | |
| 0.017 | 0.235 | 0.063 | Histamine agonist | 0.063 0.024 CHEMBL2030560 | CHEMBL2030560 | |
| 0.029 | 0.248 | 0.082 | I kappa B kinase inhibitor | 0.082 0.058 CHEMBL2030560 | CHEMBL2030560 | |
| 0.052 | 0.27 | 0.098 | Nav1.5 sodium channel blocker | 0.098 0.09 CHEMBL2030560 | CHEMBL2030560 | |
| 0.046 | 0.269 | 0.091 | Interleukin 5 antagonist | 0.091 0.053 CHEMBL2030560 | CHEMBL2030560 | |
| 0.004 | 0.228 | 0.017 | Histamine H4 receptor agonist | 0.017 0.015 CHEMBL2030560 | CHEMBL2030560 | |
| 0.014 | 0.241 | 0.083 | Argininosuccinate synthase inhibitor | 0.083 0.024 CHEMBL2030560 | CHEMBL2030560 | |
| 0.036 | 0.267 | 0.11 | 5 Hydroxytryptamine 2B antagonist | 0.11 0.072 CHEMBL2030560 | CHEMBL2030560 | |
| 0.043 | 0.275 | 0.116 | Beta amyloid protein antagonist | 0.116 0.071 CHEMBL2030560 | CHEMBL2030560 | |
| 0.033 | 0.264 | 0.155 | Glycogen synthase kinase-3 alpha inhibitor | 0.155 0.063 CHEMBL2030560 | CHEMBL2030560 | |
| 0.031 | 0.264 | 0.091 | Polo-like kinase-4 inhibitor | 0.091 0.086 CHEMBL2030560 | CHEMBL2030560 | |
| 0.019 | 0.255 | 0.072 | Porphobilinogen synthase inhibitor | 0.072 0.054 CHEMBL2030560 | CHEMBL2030560 | |
| 0.027 | 0.268 | 0.131 | Alcohol dehydrogenase inhibitor | 0.131 0.028 CHEMBL2030560 | CHEMBL2030560 | |
| 0.062 | 0.303 | 0.22 | MAP kinase kinase 2 inhibitor | 0.22 0.07 CHEMBL2030560 | CHEMBL2030560 | |
| 0.038 | 0.283 | 0.083 | GABA B receptor agonist | 0.083 0.036 CHEMBL2030560 | CHEMBL2030560 | |
| 0.052 | 0.297 | 0.155 | TRKC antagonist | 0.155 0.097 CHEMBL2030560 | CHEMBL2030560 | |
| 0.045 | 0.294 | 0.098 | Activin receptor-like kinase 4 inhibitor | 0.098 0.09 CHEMBL2030560 | CHEMBL2030560 | |
| 0.002 | 0.263 | 0.009 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.009 0.004 CHEMBL2030560 | CHEMBL2030560 | |
| 0.075 | 0.34 | 0.154 | Focal adhesion kinase 2 inhibitor | 0.154 0.125 CHEMBL2030560 | CHEMBL2030560 | |
| 0.023 | 0.289 | 0.082 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 CHEMBL2030560 | CHEMBL2030560 | |
| 0.033 | 0.302 | 0.105 | GABA C receptor antagonist | 0.105 0.07 CHEMBL2030560 | CHEMBL2030560 | |
| 0.038 | 0.308 | 0.139 | Psychostimulant | 0.139 0.126 CHEMBL2030560 | CHEMBL2030560 | |
| 0.013 | 0.294 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.038 0.019 CHEMBL2030560 | CHEMBL2030560 | |
| 0.056 | 0.339 | 0.294 | Interleukin agonist | 0.294 0.051 CHEMBL2030560 | CHEMBL2030560 | |
| 0.056 | 0.339 | 0.158 | Hexokinase inhibitor | 0.158 0.07 CHEMBL2030560 | CHEMBL2030560 | |
| 0.059 | 0.353 | 0.159 | Polo-like kinase-3 inhibitor | 0.159 0.075 CHEMBL2030560 | CHEMBL2030560 | |
| 0.034 | 0.328 | 0.206 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.206 0.061 CHEMBL2030560 | CHEMBL2030560 | |
| 0.011 | 0.306 | 0.063 | Phosphofructokinase-1 inhibitor | 0.063 0.054 CHEMBL2030560 | CHEMBL2030560 | |
| 0.014 | 0.324 | 0.056 | Bromodomain-containing protein 4 inhibitor | 0.056 0.036 CHEMBL2059159 | CHEMBL2059159 | |
| 0.028 | 0.34 | 0.118 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.118 0.085 CHEMBL2030560 | CHEMBL2030560 | |
| 0.036 | 0.352 | 0.13 | DNA polymerase I inhibitor | 0.13 0.061 CHEMBL2030560 | CHEMBL2030560 | |
| 0.066 | 0.386 | 0.166 | Neurotrophic factor enhancer | 0.166 0.115 CHEMBL2030560 | CHEMBL2030560 | |
| 0.025 | 0.347 | 0.082 | Glutamate dehydrogenase inhibitor | 0.082 0.043 CHEMBL2030560 | CHEMBL2030560 | |
| 0.026 | 0.349 | 0.123 | Nitric-oxide synthase inhibitor | 0.123 0.036 CHEMBL2030560 | CHEMBL2030560 | |
| 0.046 | 0.371 | 0.14 | Cyclin-dependent kinase 8 inhibitor | 0.14 0.09 CHEMBL2030560 | CHEMBL2030560 | |
| 0.083 | 0.414 | 0.179 | 5 Hydroxytryptamine release stimulant | 0.179 0.142 CHEMBL2030560 | CHEMBL2030560 | |
| 0.044 | 0.389 | 0.08 | T cell inhibitor | 0.08 0.068 CHEMBL2030560 | CHEMBL2030560 | |
| 0.075 | 0.433 | 0.197 | MAP-kinase-activated kinase 5 inhibitor | 0.197 0.107 CHEMBL2030560 | CHEMBL2030560 | |
| 0.045 | 0.418 | 0.195 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.195 0.08 CHEMBL2030560 | CHEMBL2030560 | |
| 0.037 | 0.418 | 0.11 | Nav1.2 sodium channel blocker | 0.11 0.096 CHEMBL2030560 | CHEMBL2030560 | |
| 0.047 | 0.428 | 0.148 | Antipruritic | 0.148 0.097 CHEMBL2030560 | CHEMBL2030560 | |
| 0.113 | 0.526 | 0.331 | MAP kinase kinase 3 inhibitor | 0.331 0.004 CHEMBL2059159 0.194 0.142 CHEMBL2030560 | CHEMBL2059159 | |
| 0.069 | 0.486 | 0.232 | Immunomodulator | 0.232 0.13 CHEMBL2030560 | CHEMBL2030560 | |
| 0.03 | 0.454 | 0.16 | Death-associated protein kinase 3 inhibitor | 0.16 0.108 CHEMBL2030560 | CHEMBL2030560 | |
| 0.03 | 0.466 | 0.142 | Phosphodiesterase 7B inhibitor | 0.142 0.025 CHEMBL2030560 | CHEMBL2030560 | |
| 0.008 | 0.456 | 0.077 | Dopamine transporter inhibitor | 0.077 0.018 CHEMBL2059159 | CHEMBL2059159 | |
| 0.052 | 0.505 | 0.171 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.171 0.117 CHEMBL2030560 | CHEMBL2030560 | |
| 0.01 | 0.493 | 0.068 | Adrenaline uptake inhibitor | 0.068 0.037 CHEMBL2059159 | CHEMBL2059159 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |